HomeCYTK • NASDAQ
Cytokinetics, Inc.
add
$40.25
7.33%
After Hours:(2.98%)-1.20
$39.05
Closed: Apr 2, 6:56:58 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 16.93M | 912.38% |
Operating expense | 62.34M | 41.31% |
Net income | -150.02M | -9.59% |
Net profit margin | -886.28 | 89.18% |
Earnings per share | -1.26 | 8.70% |
EBITDA | -136.66M | -12.86% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.08B | 75.01% |
Total assets | 1.40B | 70.04% |
Total liabilities | 1.54B | 26.96% |
Total equity | -135.37M | — |
Shares outstanding | 118.41M | — |
Price to book | -32.61 | — |
Return on assets | -24.50% | — |
Return on capital | -41.33% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -150.02M | -9.59% |
Cash from operations | -65.57M | 11.44% |
Cash from investing | 110.86M | 236.18% |
Cash from financing | 2.38M | -98.59% |
Net change in cash | 47.97M | 259.80% |
Free cash flow | -40.46M | 2.24% |
Previous close
$37.50
Day range
$40.16 - $43.69
Year range
$37.46 - $75.66
Market cap
4.77B USD
Avg Volume
1.74M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
Founded
1997
Headquarters
Website
Employees
498
